antimony has been researched along with Inflammation in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Arruda, S; Carvalho, AM; Carvalho, EM; Carvalho, LP; Costa, R; Guimarães, LH; Prates, I; Saldanha, MG | 1 |
Campos, TM; Carvalho, EM; Carvalho, LP; Costa, RS; Lago, E; Machado, P; Magalhães, AS; Paixão, CS; Passos, ST; Schriefer, A; Scott, P; Silva, JA | 1 |
Barbieri, LC; Barreto, CC; Carvalho, E; Dutra, WO; Faria, DR; Gollob, KJ; Koh, CC; Lessa, MM; Lima, CMF; Machado, PRL | 1 |
Cardoso, TN; Dalastra Laurenti, M; de Paula Coelho, C; Perez Hurtado, EC; Roberti Benites, N; Rodrigues de Santana, F; Villano Bonamin, L | 1 |
Di Cerbo, A; Gatti, AM; Guildford, AL; Osbourne, LH; Poletti, T; Santin, M | 1 |
Bulut, V; Gur, S; Gurel, MS; Kocyigit, A; Ulukanligil, M | 1 |
2 trial(s) available for antimony and Inflammation
Article | Year |
---|---|
In Situ Cellular Response Underlying Successful Treatment of Mucosal Leishmaniasis with a Combination of Pentavalent Antimonial and Pentoxifylline.
Topics: Adult; Aged; Antimony; Antiprotozoal Agents; Cytokines; Double-Blind Method; Drug Therapy, Combination; Female; Granzymes; Humans; Inflammation; Leishmaniasis, Mucocutaneous; Male; Middle Aged; Pentoxifylline; Random Allocation; T-Lymphocytes; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2019 |
Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Cytokines; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2002 |
4 other study(ies) available for antimony and Inflammation
Article | Year |
---|---|
Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
Topics: Adolescent; Adult; Aged; Antimony; Brazil; CD8-Positive T-Lymphocytes; Cytokines; Female; Granzymes; Humans; Inflammation; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Matrix Metalloproteinase 9; Middle Aged; Necrosis; Skin; Th1 Cells; Young Adult | 2021 |
Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.
Topics: Adult; Antimony; Antiprotozoal Agents; Cross-Sectional Studies; Cytokines; Female; Humans; Inflammation; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Secondary Prevention; Treatment Failure; Young Adult | 2018 |
Modulation of inflammation response to murine cutaneous Leishmaniasis by homeopathic medicines: Antimonium crudum 30cH.
Topics: Animals; Antimony; Brazil; Disease Models, Animal; Homeopathy; Inflammation; Leishmaniasis, Cutaneous; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Spleen | 2014 |
Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response.
Topics: Adult; Antimony; Biochemistry; Cytokines; Female; Humans; Immunohistochemistry; Inflammation; Macrophages; Male; Middle Aged; Monocytes; Nanoparticles; Nanotechnology; Nickel; Phenotype; Platelet Activation; Silver; Time Factors; Tumor Necrosis Factor-alpha | 2009 |